Cardiac Function Improvement and Bone Marrow Response -: Outcome Analysis of the Randomized PERFECT Phase III Clinical Trial of Intramyocardial CD133(+) Application After Myocardial Infarction.
EBioMedicine（2017）
摘要
Image 3
更多查看译文
关键词
Randomised double-blinded phase III multicentre trial,CD133+,CD34+,Endothelial progenitor cell (EPC),SH2B3,Lnk adaptor,Cardiac repair,Cardiac stem cell therapy,Angiogenesis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要